Patents-Review.com
🔗 Permalink
Assignee profile:

Graceway Pharmaceuticals. LLC

City:

Bristol, Tennessee

Country:

United States

Published Applications:

20

Last publication date:

2012-02-09

Patent Grants:

13

Last grant date:

2014-09-16

Top Inventors for applications by Graceway Pharmaceuticals. LLC

These are the the leading inventors for applications assigned to Graceway Pharmaceuticals. LLC:

Recent patent applications by Graceway Pharmaceuticals. LLC

Graceway Pharmaceuticals. LLC based in Bristol, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2012-02-09 ✅ Patent 8,835,394 granted on 2014-09-16
US20120035205A1
Human necessities

Treatment for basal cell carcinoma

 #2 | 2011-10-27
US20110263637A1
Human necessities

UP TO SIX WEEKS DOSING REGIMEN FOR TREATING ACTINIC KERATOSIS WITH PHARMACEUTICAL COMPOSITIONS FORMULATED WITH 3.75% IMIQUIMOD

 #3 | 2011-10-27
US20110263636A1
Human necessities

3 x 3 x 3 WEEK DOSING REGIMEN FOR TREATING ACTINIC KERATOSIS WITH PHARMACEUTICAL COMPOSITIONS FORMULATED WITH 3.75 % IMIQUIMOD

 #4 | 2011-10-27 ✅ Patent 8,242,155 granted on 2012-08-14
US20110263635A1
Human necessities

Method of treating actinic keratosis with 3.75% imiquimod cream

 #5 | 2011-10-20
US20110257219A1
Human necessities

LOWER DOSAGE STRENGTH PHARMACEUTICAL COMPOSITIONS FORUMLATED WITH 3.75% IMIQUIMOD

 #6 | 2011-10-20 ✅ Patent 8,236,816 granted on 2012-08-07
US20110257218A1
Human necessities

2×2×2 week dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75 % imiquimod

 #7 | 2011-09-15 ✅ Patent 8,455,512 granted on 2013-06-04
US20110224251A1
Chemistry; metallurgy

Therapeutic pyrazolyl thienopyridines

 #8 | 2011-08-25
US20110207766A1
Human necessities

LOWER DOSAGE STRENGTH IMIQUIMOD FORMULATIONS AND SHORT DOSING REGIMENS FOR TREATING GENITAL AND PERIANAL WARTS

 #9 | 2011-01-27
US20110021555A1
Human necessities

LOWER DOSAGE STRENGTH IMIQUIMOD FORMULATIONS AND SHORTER DOSING REGIMENS FOR TREATING ACTINIC KERATOSES

 #10 | 2010-12-23 ✅ Patent 7,981,936 granted on 2011-07-19
US20100324145A1
Chemistry; metallurgy

Crystalline ACAT inhibitor

 #11 | 2010-09-30 ✅ Patent 8,242,286 granted on 2012-08-14
US20100247471A1
Chemistry; metallurgy

Phenoxy-pyrrolidine derivative and its use and compositions

 #12 | 2010-08-05
US20100197722A1
Human necessities

Treatment for basal cell carcinoma

 #13 | 2010-05-06 ✅ Patent 8,409,595 granted on 2013-04-02
US20100113601A1
Human necessities

Method for decreasing sebum production

 #14 | 2010-04-15
US20100092401A1
Human necessities

IMMUNE RESPONSE MODIFIER FORMULATIONS

 #15 | 2008-05-22 ✅ Patent 7,696,159 granted on 2010-04-13
US20080119572A1
Human necessities

Treatment for basal cell carcinoma

 #16 | 2008-04-17 ✅ Patent 7,678,918 granted on 2010-03-16
US20080091010A1
Chemistry; metallurgy

Intermediates for imidazonaphthyridines

 #17 | 2008-04-17 ✅ Patent 7,964,612 granted on 2011-06-21
US20080090861A1
Chemistry; metallurgy

Therapeutic pyrazolyl thienopyridines

 #18 | 2006-08-24 ✅ Patent 7,622,610 granted on 2009-11-24
US20060189697A1
Chemistry; metallurgy

Crystalline ACAT inhibitor

 #19 | 2006-06-15 ✅ Patent 7,335,773 granted on 2008-02-26
US20060128674A1
Chemistry; metallurgy

Intermediates for imidazonaphthyridines

 #20 | 2005-04-14 ✅ Patent 7,615,230 granted on 2009-11-10
US20050079144A1
Human necessities

Method for decreasing sebum production
AssigneeID:

176131 ⎘